Wisdomtree Biorevolution Etf Profile
| WDNA Etf | USD 13.11 0.34 2.66% |
PerformanceVery Weak
| Odds Of DistressLow
|
WisdomTree BioRevolution is trading at 13.11 as of the 7th of June 2025, a 2.66 percent increase since the beginning of the trading day. The etf's open price was 12.77. WisdomTree BioRevolution has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of June 2023 and ending today, the 7th of June 2025. Click here to learn more.
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. More on WisdomTree BioRevolution
Moving together with WisdomTree Etf
WisdomTree Etf Highlights
| Thematic Ideas | (View all Themes) |
| Business Concentration | Theme ETFs, Strategy ETFs, Health, WisdomTree (View all Sectors) |
| Issuer | WisdomTree |
| Inception Date | 2021-06-03 |
| Benchmark | WisdomTree BioRevolution Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 1.9 Million |
| Asset Type | Equity |
| Category | Strategy |
| Focus | Theme |
| Market Concentration | Developed Markets |
| Region | Global |
| Administrator | State Street Bank and Trust Company |
| Advisor | WisdomTree Asset Management, Inc. |
| Custodian | State Street Bank and Trust Company |
| Distributor | Foreside Fund Services, LLC |
| Portfolio Manager | Marlene Walker-Smith, Thomas J. Durante |
| Transfer Agent | State Street Bank and Trust Company |
| Fiscal Year End | 30-Jun |
| Exchange | Cboe BZX Exchange, Inc. |
| Number of Constituents | 102 |
| Market Maker | Flow Traders |
| Total Expense | 0.45 |
| Management Fee | 0.45 |
| Country Name | USA |
| Returns Y T D | (8.74) |
| Name | WisdomTree BioRevolution Fund |
| Currency Code | USD |
| Open Figi | BBG0119987C0 |
| In Threey Volatility | 22.97 |
| 1y Volatility | 20.16 |
| 200 Day M A | 14.6185 |
| 50 Day M A | 12.503 |
| Code | WDNA |
| Updated At | 7th of June 2025 |
| Currency Name | US Dollar |
| In Threey Sharp Ratio | (0.6) |
WisdomTree BioRevolution [WDNA] is traded in USA and was established 2021-06-01. The fund is listed under Health category and is part of WisdomTree family. The entity is thematically classified as Theme ETFs. WisdomTree BioRevolution at this time have 4.54 M in net assets. , while the total return for the last 3 years was -8.8%.
Check WisdomTree BioRevolution Probability Of Bankruptcy
Geographic Allocation (%)
WisdomTree BioRevolution Currency Exposure
WisdomTree BioRevolution holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of WisdomTree BioRevolution will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in WisdomTree BioRevolution.
Top WisdomTree BioRevolution Etf Constituents
| A | Agilent Technologies | Stock | Health Care | |
| AGEN | Agenus Inc | Stock | Health Care | |
| BIIB | Biogen Inc | Stock | Health Care | |
| DHR | Danaher | Stock | Health Care | |
| EDIT | Editas Medicine | Stock | Health Care | |
| ILMN | Illumina | Stock | Health Care | |
| LLY | Eli Lilly and | Stock | Health Care | |
| RGEN | Repligen | Stock | Health Care |
WisdomTree BioRevolution Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in WisdomTree BioRevolution. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.01) | |||
| Treynor Ratio | (0.02) |
WisdomTree BioRevolution Against Markets
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WisdomTree BioRevolution. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
The market value of WisdomTree BioRevolution is measured differently than its book value, which is the value of WisdomTree that is recorded on the company's balance sheet. Investors also form their own opinion of WisdomTree BioRevolution's value that differs from its market value or its book value, called intrinsic value, which is WisdomTree BioRevolution's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because WisdomTree BioRevolution's market value can be influenced by many factors that don't directly affect WisdomTree BioRevolution's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between WisdomTree BioRevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if WisdomTree BioRevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WisdomTree BioRevolution's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.